The influenza vaccine: essential insights for pharmacists in South Africa

Abstract

Influenza remains a significant cause of seasonal illness and complications in South Africa, particularly among high-risk populations. This article reviews the influenza vaccination pathway from global strain selection to patient counselling, with a focus on the 2026 southern hemisphere vaccine composition. Key topics include identification of priority groups, optimal timing of vaccination, expected effectiveness, and the safety profile of inactivated influenza vaccines.

Practical guidance on vaccine administration and strategies for addressing common misconceptions are also discussed. Strengthening understanding of these elements supports informed clinical recommendations and may improve vaccine uptake, ultimately reducing the burden of influenza.